Neurophet

Neurophet Specializes in Developing Solutions for Diagnostic Support, Treatment Guidelines, and Therapeutic Devices for Brain Diseases Based on Cutting-Edge Artificial Intelligence (AI) Technology. Founded in 2016 by CEO Jake Junkil Been and CTO Donghyeon Kim, the company has developed next-generation neuro-navigation systems. Key products include brain MRI analysis software "Neurophet AQUA", brain PET scan analysis (PET tracer deposition) software "Neurophet SCALE PET", brain imaging treatment planning software for EEG and MEG stimulation "Neurophet tES/TMS LAB", and a cloud-based brain imaging analysis research tool "Neurophet SegPlus". Neurophet prioritizes aiding patients with brain diseases. Leveraging expertise in neuroscience, Neurophet will continue to challenge and grow, exploring human brain health and pioneering AI-driven solutions for brain diseases.